MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

Description

Alpelisib is a Selective and Orally Active PI3Kα Inhibitor for

Selective inhibitory activity of 9l towards H3K79 methylation in

BC-LI-0186 is a Selective Inhibitor of LeuRS and RagD Interaction

Molecules, Free Full-Text

Trilaciclib is an Orally Active CDK4 and CDK6 Inhibitor

Established synthetic method of psammaplin A analog and

OT-82 is an Orally Active NAMPT Inhibitor with Antineoplastic Activity

Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to

SG-094 is a Potent TPC2 Inhibitor for HCC Reasearch

$ 26.00USD
Score 4.9(795)
In stock
Continue to book